A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Abstract Introduction: Racial and ethnic minority groups have higher rates of SARS-CoV-2 infection, severe illness, and death; however, they receive monoclonal antibody (mAb) treatment at lower rates than non-Hispanic White patients. We report data from a systematic approach to improve equitable p...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S205986612200526X/type/journal_article |